Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Receivables - Other: 2019-2024

Historic Receivables - Other for CureVac N.V (CVAC) over the last 6 years, with Dec 2024 value amounting to $3.0 million.

  • CureVac N.V's Receivables - Other fell 20.19% to $2.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.2 million, marking a year-over-year decrease of 20.19%. This contributed to the annual value of $3.0 million for FY2024, which is 278.12% up from last year.
  • As of FY2024, CureVac N.V's Receivables - Other stood at $3.0 million, which was up 278.12% from $781,132 recorded in FY2023.
  • CureVac N.V's 5-year Receivables - Other high stood at $3.1 million for FY2021, and its period low was $781,132 during FY2023.
  • For the 3-year period, CureVac N.V's Receivables - Other averaged around $2.1 million, with its median value being $2.6 million (2022).
  • As far as peak fluctuations go, CureVac N.V's Receivables - Other surged by 161,068.34% in 2020, and later tumbled by 69.99% in 2023.
  • Over the past 5 years, CureVac N.V's Receivables - Other (Yearly) stood at $2.6 million in 2020, then climbed by 18.83% to $3.1 million in 2021, then dropped by 16.08% to $2.6 million in 2022, then plummeted by 69.99% to $781,132 in 2023, then skyrocketed by 278.12% to $3.0 million in 2024.